ElaiophylinAlternative Names: SNA 4606-3
Latest Information Update: 27 Nov 2007
At a glance
- Originator Snow Brand Milk Products
- Mechanism of Action Cholestenone 5-alpha reductase inhibitors; Testosterone antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Benign prostatic hyperplasia
Most Recent Events
- 09 Jun 1999 Preclinical development for Benign prostatic hyperplasia in Japan (unspecified route)